The interaction between gut microbiota and cardiac disease, metabolic syndrome

The interaction between gut microbiota and cardiac disease, metabolic syndrome - Cardiac disease, metabolic syndrome and gut microbiota

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027975

Enrollment

1000

Registered

2017-09-01

Start date

2018-01-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac disease (angina pectoris, valvular disease, heart failure, arrhythmia, pulmonary hypertension, and so on) Metabolic syndrome(diabetes mellitus, hypertension, hyperuricemia, and so on)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with cardiac disease and metabolic syndrome who agree to this study.

Exclusion criteria

Exclusion criteria: Patients who do not agree to this study and those who are not appropriate for t his study.

Design outcomes

Primary

Measure	Time frame
Change of gut microbiota in the patients with cardiac disease	—

Secondary

Measure	Time frame
Gut microbial metabolites in the patients with cardiac disease.	—

Countries

Japan

Contacts

Public ContactYamashita Tomoya

Kobe University Hospital Department of cardiology

tomoya@med.kobe-u.ac.jp078-382-5846

Outcome results